Liver fibrosis is independent of methotrexate use in patients with moderate-to-severe psoriasis

被引：0
|
作者：
Babakinejad, Parastoo [1 ]
Lapsley, Rebecca [1 ]
Foster, Lara [2 ]
McPherson, Stuart [1 ]
Pearce, Mark [2 ]
Reynolds, Nick [1 ]
Slack, Emma [2 ]
Weatherhead, Sophie [1 ]
Hampton, Philip [1 ]
机构：
[1] Royal Victoria Infirm, Newcastle Upon Tyne, Tyne & Wear, England
[2] Newcastle Univ, Newcastle Upon Tyne, Tyne & Wear, England
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2023年 / 188卷
关键词：
D O I：
10.1093/bjd/ljad113.096
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
P68
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Cumulative methotrexate dose is not associated with liver fibrosis in patients with a history of moderate-to-severe psoriasis
    Babakinejad, Parastoo
    Lapsley, Rebecca
    Forster, Lara
    McPherson, Stuart
    Pearce, Mark S.
    Reynolds, Nick J.
    Slack, Emma
    Weatherhead, Sophie C.
    Hampton, Philip J.
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 191 (02) : 275 - 283
  • [2] Subcutaneous methotrexate in patients with moderate-to-severe psoriasis: a critical appraisal
    Tsakok, T.
    Jabbar-Lopez, Z. K.
    Smith, C. H.
    BRITISH JOURNAL OF DERMATOLOGY, 2018, 179 (01) : 50 - 53
  • [3] Ixekizumab versus FAEs and methotrexate in treatment of nail psoriasis in patients with moderate-to-severe psoriasis
    Augustin, Matthias
    Mrowietz, Ulrich
    Willsmann-Theis, Dagmar
    Gerdes, Sascha
    Fotiou, Konstantinos
    Schuster, Christopher
    Mert, Can
    Holzkaemper, Thorsten
    Behrens, Frank
    Pinter, Andreas
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2024,
  • [4] Early identification of response with methotrexate for moderate-to-severe psoriasis
    Gordon, K.
    Sundaram, M.
    Arunajadai, S.
    Xie, M.
    Signorovitch, J.
    Betts, K.
    Okun, M.
    BRITISH JOURNAL OF DERMATOLOGY, 2014, 171 (06) : E153 - E153
  • [5] Metabolomic Alterations in Methotrexate Treatment of Moderate-to-Severe Psoriasis
    Zhou, Yi
    Ding, Yantao
    Cui, Mengxing
    Zhang, Yuanjing
    Wang, Mengwei
    Zhou, Feiran
    Su, Yi
    Liang, Bo
    Zhou, Fusheng
    MEDICAL SCIENCE MONITOR, 2024, 30
  • [6] Metabolic syndrome and female gender, but not methotrexate, are the important associations of significant liver fibrosis in patients with moderate-to-severe psoriasis as detected by transient elastography
    Mahajan, Rahul
    Dogra, Sunil
    Handa, Sanjeev
    Razmi, T. Muhammed
    Narang, Tarun
    Rathi, Sahaj
    Dhiman, Radha Krishan
    Saikia, Biman
    Karim, Adil
    INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY, 2020, 86 (06): : 649 - 655
  • [7] Use of systemic and biological therapy in patients with moderate-to-severe psoriasis
    Liljendahl, Mie S.
    Loft, Nikolai
    Nguyen, Tri-Long
    Skov, Lone
    Egeberg, Alexander
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2023, 49 (01) : 35 - 41
  • [8] Methotrexate versus cyclosporine in moderate-to-severe chronic plaque psoriasis
    Heydendael, VMR
    Spuls, PI
    Opmeer, BC
    de Borgie, CAJM
    Reitsma, JB
    Goldschmidt, WFM
    Bossuyt, PMM
    Bos, JD
    de Rie, MA
    NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (07): : 658 - 665
  • [9] The use of methotrexate in treatment of moderate to severe psoriasis
    Leung, W. Y.
    Lau, K. H.
    HONG KONG JOURNAL OF DERMATOLOGY & VENEREOLOGY, 2009, 17 (01): : 13 - 19
  • [10] Treating patients with moderate-to-severe psoriasis vulgaris
    Kessler, Timothy R.
    JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2022, 35 (03): : 28 - 35
12345